Carlotta Costa

5.3k total citations · 1 hit paper
28 papers, 1.9k citations indexed

About

Carlotta Costa is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Carlotta Costa has authored 28 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 11 papers in Oncology and 8 papers in Immunology. Recurrent topics in Carlotta Costa's work include PI3K/AKT/mTOR signaling in cancer (13 papers), Protein Kinase Regulation and GTPase Signaling (4 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers). Carlotta Costa is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (13 papers), Protein Kinase Regulation and GTPase Signaling (4 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers). Carlotta Costa collaborates with scholars based in United States, Italy and United Kingdom. Carlotta Costa's co-authors include Emilio Hirsch, Jeffrey A. Engelman, Elisa Ciraolo, Youngchul Song, Anthony C. Faber, Alexa B. Turke, Rebecca S. Cook, Carlos L. Arteaga, John M. Asara and Hiromichi Ebi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Carlotta Costa

27 papers receiving 1.9k citations

Hit Papers

CDK 4/6 Inhibitors Sensitize PIK3CA Mutant Breast Cancer ... 2014 2026 2018 2022 2014 100 200 300

Peers

Carlotta Costa
Alice Loo United States
Yoon Jong Choi United States
Malte Peters United States
David R. Emlet United States
Landon J. Inge United States
Keith Orford United States
Alice Loo United States
Carlotta Costa
Citations per year, relative to Carlotta Costa Carlotta Costa (= 1×) peers Alice Loo

Countries citing papers authored by Carlotta Costa

Since Specialization
Citations

This map shows the geographic impact of Carlotta Costa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlotta Costa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlotta Costa more than expected).

Fields of papers citing papers by Carlotta Costa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlotta Costa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlotta Costa. The network helps show where Carlotta Costa may publish in the future.

Co-authorship network of co-authors of Carlotta Costa

This figure shows the co-authorship network connecting the top 25 collaborators of Carlotta Costa. A scholar is included among the top collaborators of Carlotta Costa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlotta Costa. Carlotta Costa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Lang Ho, Fanying Tang, Lauren Fairchild, et al.. (2025). Defining Non–small Cell Lung Cancer Tumor Microenvironment Changes at Primary and Acquired Immune Checkpoint Inhibitor Resistance Using Clinical and Real-World Data. Cancer Research Communications. 5(6). 1049–1059.
2.
Jacob, Sheeba, Jinyang Cai, Konstantinos V. Floros, et al.. (2022). Genomic screening reveals ubiquitin-like modifier activating enzyme 1 as a potent and druggable target in c-MYC-high triple negative breast cancer models. PNAS Nexus. 1(5). pgac232–pgac232. 6 indexed citations
3.
Dastur, Anahita, Carlotta Costa, August Williams, et al.. (2018). NOTCH1 Represses MCL-1 Levels in GSI-resistant T-ALL, Making them Susceptible to ABT-263. Clinical Cancer Research. 25(1). 312–324. 16 indexed citations
4.
Lochmann, Timothy L., Konstantinos V. Floros, Mitra Naseri, et al.. (2017). Venetoclax Is Effective in Small-Cell Lung Cancers with High BCL-2 Expression. Clinical Cancer Research. 24(2). 360–369. 93 indexed citations
5.
Costa, Carlotta & Jeffrey A. Engelman. (2014). The Double Life of p85. Cancer Cell. 26(4). 445–447. 16 indexed citations
6.
Franco, Irene, Federico Gulluni, Carlo Cosimo Campa, et al.. (2014). PI3K Class II α Controls Spatially Restricted Endosomal PtdIns3P and Rab11 Activation to Promote Primary Cilium Function. Developmental Cell. 28(6). 647–658. 158 indexed citations
7.
Vora, Sadhna, Dejan Juric, Mari Mino–Kenudson, et al.. (2014). CDK 4/6 Inhibitors Sensitize PIK3CA Mutant Breast Cancer to PI3K Inhibitors. Cancer Cell. 26(1). 136–149. 351 indexed citations breakdown →
8.
Costa, Carlotta, Hiromichi Ebi, Miriam Martini, et al.. (2014). Measurement of PIP3 Levels Reveals an Unexpected Role for p110β in Early Adaptive Responses to p110α-Specific Inhibitors in Luminal Breast Cancer. Cancer Cell. 27(1). 97–108. 142 indexed citations
9.
Ebi, Hiromichi, Carlotta Costa, Anthony C. Faber, et al.. (2013). PI3K regulates MEK/ERK signaling in breast cancer via the Rac-GEF, P-Rex1. Proceedings of the National Academy of Sciences. 110(52). 21124–21129. 174 indexed citations
10.
Turke, Alexa B., Youngchul Song, Carlotta Costa, et al.. (2012). MEK Inhibition Leads to PI3K/AKT Activation by Relieving a Negative Feedback on ERBB Receptors. Cancer Research. 72(13). 3228–3237. 285 indexed citations
11.
Faber, Anthony C., Hiromichi Ebi, Carlotta Costa, & Jeffrey A. Engelman. (2012). Apoptosis In Targeted Therapy Responses. Advances in pharmacology. 65. 519–542. 50 indexed citations
12.
Costa, Carlotta, Giulia Germena, E. Conte, et al.. (2011). The RacGAP ArhGAP15 is a master negative regulator of neutrophil functions. Blood. 118(4). 1099–1108. 39 indexed citations
13.
Costa, Carlotta, E. Conte, & Emilio Hirsch. (2011). Phosphoinositide 3-kinase p110γ in immunity. IUBMB Life. 63(9). n/a–n/a. 28 indexed citations
14.
Spiller, Fernando, Carlotta Costa, Fabrício Oliveira Souto, et al.. (2010). Inhibition of Neutrophil Migration by Hemopexin Leads to Increased Mortality Due to Sepsis in Mice. American Journal of Respiratory and Critical Care Medicine. 183(7). 922–931. 34 indexed citations
15.
Costa, Carlotta & Emilio Hirsch. (2010). More Than Just Kinases: The Scaffolding Function of PI3K. Current topics in microbiology and immunology. 346. 171–181. 18 indexed citations
16.
Barberis, Laura, Christian Pasquali, Carlotta Costa, et al.. (2009). Leukocyte transmigration is modulated by chemokine‐mediated PI3Kγ‐dependent phosphorylation of vimentin. European Journal of Immunology. 39(4). 1136–1146. 54 indexed citations
17.
Ambrogio, Chiara, Claudia Voena, Andrea D. Manazza, et al.. (2008). The Anaplastic Lymphoma Kinase Controls Cell Shape and Growth of Anaplastic Large Cell Lymphoma through Cdc42 Activation. Cancer Research. 68(21). 8899–8907. 41 indexed citations
18.
Hirsch, Emilio, Elisa Ciraolo, Alessandra Ghigo, & Carlotta Costa. (2008). Taming the PI3K team to hold inflammation and cancer at bay. Pharmacology & Therapeutics. 118(2). 192–205. 57 indexed citations
19.
Hirsch, Emilio, Carlotta Costa, & Elisa Ciraolo. (2007). Phosphoinositide 3-kinases as a common platform for multi-hormone signaling. Journal of Endocrinology. 194(2). 243–256. 109 indexed citations
20.
Cappello, Paola, Tiziana Fraone, Laura Barberis, et al.. (2006). CC-Chemokine Ligand 16 Induces a Novel Maturation Program in Human Immature Monocyte-Derived Dendritic Cells. The Journal of Immunology. 177(9). 6143–6151. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026